Vladimir Egorov

Dr. Vladimir Egorov

Macromolecular Biophysics Laboratory, Petersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Center «Kurchatov Institute», 1, Orlova roscha mcr., Gatchina, Leningrad region, 188300, Russia
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Virus Research
Verified
Journal Article
Closed access
AVAndrey Vasin
Andrey Vasin
OTO.A. Temkina
O.A. Temkina
Vladimir EgorovVladimir Egorov
Vladimir Egorov
SKSergei Klotchenko
Sergei Klotchenko
MPM.A. Plotnikova
M.A. Plotnikova
OKO.I. Kiselev
O.I. Kiselev

30 January 2014 in Technical Physics
Verified
Journal Article
Closed access
PDF file
OKO. I. Ksenofontova
O. I. Ksenofontova
AVAndrey Vasin
Andrey Vasin
Vladimir EgorovVladimir Egorov
Vladimir Egorov
ABAlexander Bobyl
Alexander Bobyl
FSF. Yu. Soldatenkov
F. Yu. Soldatenkov
OKO. I. Kiselev
O. I. Kiselev
Development of safe container materials for targeted and controlled drug delivery to the right site in the body is one of the most important aspects of modern biotechnologies. In the last decade, a...

31 January 2021 in Polymers
Verified
Journal Article
Open access
PDF file
MSMaria Slyusarenko
Maria Slyusarenko
Nadezhda NikiforovaNadezhda Nikiforova
Nadezhda Nikiforova
ESElena Sidina
Elena Sidina
INInga Nazarova
Inga Nazarova
Vladimir EgorovVladimir Egorov
Vladimir Egorov
Anastasia MalekAnastasia Malek
Anastasia Malek
The aim of the study was to explore the polyethylene glycol–dextran two-phase polymer system formed in human plasma to isolate the exosome-enriched fraction of plasma extracellular nanovesicles (ENVs). Systematic analysis was performed to determine the optimal combination of the polymer mixture parameters (molecular mass and concentration) that resulted in phase separation. The separated phases were analyzed by nanoparticle tracking analysis and Raman spectroscopy. The isolated vesicles were characterized by atomic force microscopy and dot blotting. In conclusion, the protein and microRNA contents of the isolated ENVs were assayed by flow cytometry and by reverse transcription followed by quantitative polymerase chain reaction (RT-qPCR), respectively. The presented results revealed the applicability of a new method for plasma ENV isolation and further analysis with a diagnostic purpose.

3 October 2011 in Preparative Biochemistry & Biotechnology
Verified
Journal Article
Closed access
KSK. V. Solovyov
K. V. Solovyov
DPDmitry Polyakov
Dmitry Polyakov
NGN. A. Grudinina
N. A. Grudinina
Vladimir EgorovVladimir Egorov
Vladimir Egorov
IMI. V. Morozova
I. V. Morozova
MSM. M. Shavlovsky
M. M. Shavlovsky
The possibility of obtaining recombinant fibrillogenic fusion proteins such as transthyretin (TTR) and β2-microglobulin (β2M) with a superfolder green fluorescent protein (sfGFP) was studied. According to the literature data, sfGFP is resistant to denaturating influences, does not aggregate during renaturation, possesses improved kinetic characteristics of folding, and folds well when fused to different polypeptides. The corresponding DNA constructs for expression in Escherichia coli were created. It could be shown that during expression of these constructs in E. coli, soluble forms of the fusion proteins are synthesized. Efficient isolation of the fusion proteins was performed with the help of nickel-affinity chromatography. For this purpose a polyhistidine sequence (6-His-tag) was incorporated into the C-terminus of the sfGFP. We could show that the purified fusion proteins contained full-size sequences of the most amyloidogenic TTR variant, TTR(L55P) and β2M, and also sfGFP possessing fluorescent properties. In the course of fibrillogenesis both fusion proteins demonstrated their ability to form fibrils that were clearly detectable by atomic force microscopy. Furthermore, with the help of confocal microscopy we were able to reveal structures (exhibiting fluorescence) that are formed during fibrillogenesis. Thus, the use of sfGFP has made it possible to avoid formation of inclusion bodies (IB) during the synthesis of recombinant fusion proteins and to obtain soluble forms of TTR(L55P) and β2M that are suitable for further studies.

13 October 2010 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MJMarina Jerebtsova
Marina Jerebtsova
SKSergei Klotchenko
Sergei Klotchenko
TATatiana O. Artamonova
Tatiana O. Artamonova
TATatiana Ammosova
Tatiana Ammosova
KWKareem Washington
Kareem Washington
SNSergei Nekhai
Sergei Nekhai

1 March 2018 in Biophysical Chemistry
Verified
Journal Article
Closed access
Yana ZabrodskayaYana Zabrodskaya
Yana Zabrodskaya
DLDmitry V. Lebedev
Dmitry V. Lebedev
MEMarja A. Egorova
Marja A. Egorova
ASAram A. Shaldzhyan
Aram A. Shaldzhyan
ASAlexey Shvetsov
Alexey Shvetsov
Vladimir EgorovVladimir Egorov
Vladimir Egorov